China Biologic Products Holdings
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
5/10
|
31.4 | 48.77 | -35.62% | 29.56 | 6.23% |
| P/S |
|
9.1 | 33.76 | -73.04% |
|
|
| P/BV |
|
2.3 | 4.82 | -52.29% |
|
|
| P/FCF |
|
19.22 | 60.98 | -68.49% |
|
|
| Ev/Ebitda |
|
15.65 | -22.12 | -170.75% |
|
|
| Ev/S |
|
6.42 | 22.56 | -71.53% |
|
|
| Ev/FCF |
|
14.19 | 68.75 | -79.36% |
|
|
| E/P |
|
0.0334 | 0.0178 | 87.92% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
29.04 | 4.83 | 501.2% | 39.81 | -27.05% |
| ROE |
|
7.86 | 9.61 | -18.18% |
|
|
| ROA |
|
6.91 | 0.3359 | 1957.13% |
|
|
| ROIC |
|
7.43 | 7.63 | -2.68% |
|
|
| ROS |
|
29.04 | -25.17 | -215.37% |
|
|
| ROCE |
|
0 | 15.33 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | -3.67 | -100% | 0.0072 | -100% |
| Nеt Debt/Ebitda |
|
-5.54 | -3.44 | 60.97% |
|
|
| Debt/Ratio |
|
0 | 0.1972 | -100% |
|
|
| Debt/Equity |
|
0 | 1.65 | -100% |
|
|
| Debt/Net Income |
|
0 | 10.31 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5491 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0 | 0.2043 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0591 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
26.23 | 43.56 | -39.78% |
|
|
| Difference from average difference in sector |
|
-0.5491 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
6/10
|
41.58 | -56.89 | -173.09% |
| Growth impulse Ebitda 5 years |
|
49.6 | -64.81 | -176.53% |
| Growth impulse Net Income 5 years |
|
124.3 | -58.33 | -313.1% |
| Growth impulse FCF 5 years |
|
271.52 | -47 | -677.7% |
| Growth impulse EPS 5 years |
|
59.76 | -32.41 | -284.39% |
IP Score
5.74/10
